Evidence mapPaperPMID 41003973Full record

ReviewInflammopharmacology2025

Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets.

M V N L Chaitanya, Deepshikha Patle, Sachin Kumar Singh, Avijit Mazumder, Rakesh Kumar Sindhu, Kamal Dua, Navneet Khurana, Prince Arora

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M V N L ChaitanyaSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi, Grand Trunk Rd, Phagwara, Punjab, 144411, India. mvnlcdiamond@gmail.com.ORCID http://orcid.org/0000-0001-9432-2374
Deepshikha PatleSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi, Grand Trunk Rd, Phagwara, Punjab, 144411, India.
Sachin Kumar SinghSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi, Grand Trunk Rd, Phagwara, Punjab, 144411, India.
Avijit MazumderNoida Institute of Engineering and Technology (Pharmacy Institute), 19 Knowledge Park II, Institutional Area, Greater Noida, 201306, India.
Rakesh Kumar SindhuDepartment of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, 125001, Haryana, India.
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Navneet KhuranaSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi, Grand Trunk Rd, Phagwara, Punjab, 144411, India.
Prince AroraSchool of Computer Applications, Lovely Professional University, Jalandhar-Delhi, Grand Trunk Rd, Phagwara, Punjab, 144411, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salidroside (SAL), a phenylpropanoid glycoside found in Rhodiola rosea L. roots, is one of the plant's most essential active components. Few studies have shown that it has many health advantages, particularly because it helps combat inflammation, prevent cell death, and protect cells from harm. Research indicated that SAL may protect cardiac myocytes from oxidative stress and enhance glucose uptake in skeletal muscle cells. It also significantly enhanced mitochondrial activity and prevented cell death in pheochromocytoma cells, SH-SY5Y neuroblastoma cells, and cardiomyocytes. Besides its advantages for cellular function, SAL is recognised for its protective effects on the heart and brain. Animal studies have shown efficacy in reducing lung damage induced by LPS and sepsis resulting from caecal ligation and puncture in murine models. SAL seems to enhance insulin resistance via activating a route that links mitochondria to AMPK, PI3K, Akt, and GSK-3β. Aqueous preparations of Rhodiola rosea have shown metabolic benefits by reducing blood glucose levels in streptozotocin-treated diabetic rats, an effect that is negated upon adrenal gland removal. The extensive array of pharmacological effects underscores the considerable therapeutic potential of SAL. Despite the well-documented advantages of SAL, research gaps persist regarding optimal dose, long-term safety, and comprehensive effectiveness comparisons in clinical environments. To assist researchers and clinicians in the biomedical sector in filling in the gaps in their knowledge and gaining a comprehensive picture of SAL's therapeutic applications and mechanisms, this review compiles the numerous results on these topics. It aims to simplify complicated material and highlight areas that need more investigation by integrating our present knowledge of SALs and their sources, biosynthesis, extraction, analysis, pharmacological effects, and molecular processes.

Indexed as

GlucosidesInflammationPhenolsAnimalsHumansOxidative StressRhodiolaGlucosidesPhenolsrhodiolosideAntidiabetesCellular inflammationMitochondrial activityRhodiola roseaSalidrosideSH-SY5Y neuroblastoma cells

Identifiers

PMID41003973

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.